Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Kakuda, Thomas N
117  Ergebnisse:
Personensuche X
?
1

JNJ-73763989 and bersacapavir treatment in nucleos(t)ide an..:

Agarwal, Kosh ; Buti, Maria ; van Bömmel, Florian...
Journal of Hepatology.  , 2024
Link: https://doi.org/10.1016/..
 
?
2

Pharmacokinetics of JNJ‐73763989 and JNJ‐56136379 (Bersacap..:

Kakuda, Thomas N. ; Halabi, Atef ; Klein, Gernot...
The Journal of Clinical Pharmacology.  63 (2023)  6 - p. 732-741 , 2023
Link: https://doi.org/10.1002/..
 
?
3

Drug‐Drug Interactions With the Hepatitis B Virus Capsid As..:

Vandenbossche, Joris ; Yogaratnam, Jeysen ; Hillewaert, Vera...
Clinical Pharmacology in Drug Development.  11 (2022)  12 - p. 1419-1429 , 2022
Link: https://doi.org/10.1002/..
 
?
4

Safety, antiviral activity and pharmacokinetics of JNJ-6453..:

Gane, Ed J. ; Schwabe, Christian ; Berliba, Elina...
Journal of Antimicrobial Chemotherapy.  77 (2022)  4 - p. 1102-1110 , 2022
Link: https://doi.org/10.1093/..
 
?
5

Pharmacokinetics, Safety, and Tolerability of the siRNA JNJ..:

Li, Haiyan ; Niu, Xiaoye ; Zhang, Yu...
Clinical Pharmacology in Drug Development.  12 (2022)  2 - p. 175-180 , 2022
Link: https://doi.org/10.1002/..
 
?
6

JNJ-73763989 pharmacokinetics and safety: Liver-targeted si..:

Gane, Ed ; Yuen, Man-Fung ; Kakuda, Thomas N...
Antiviral Therapy.  27 (2022)  3 - p. 135965352210938 , 2022
Link: https://doi.org/10.1177/..
 
?
7

Antiviral Activity, Safety, and Pharmacokinetics of Capsid ..:

Yuen, Man Fung ; Gane, Edward J. ; Kim, Dong Joon...
Gastroenterology.  156 (2019)  5 - p. 1392-1403.e7 , 2019
Link: https://doi.org/10.1053/..
 
?
8

Population Pharmacokinetics of AL-335 and Its Two Main Meta..:

Valade, Elodie ; Kakuda, Thomas N. ; McClure, Matthew W....
The AAPS Journal.  21 (2018)  1 - p. , 2018
Link: https://doi.org/10.1208/..
 
?
9

Antiviral Activity, Safety, and Pharmacokinetics of AL-794,..:

Yogaratnam, Jeysen ; Rito, Jennifer ; Kakuda, Thomas N...
The Journal of Infectious Diseases.  219 (2018)  2 - p. 177-185 , 2018
Link: https://doi.org/10.1093/..
 
?
10

Pharmacokinetics, safety, and tolerability of the 2‐ and 3‐..:

Kakuda, Thomas N. ; McClure, Matthew W. ; Westland, Christopher...
Pharmacology Research & Perspectives.  6 (2018)  3 - p. , 2018
Link: https://doi.org/10.1002/..
 
?
11

Short‐Duration AL‐335, Odalasvir, With or Without Simeprevi..:

Gane, Edward J. ; Stedman, Catherine A. ; Schwabe, Christian...
Hepatology.  68 (2018)  6 - p. 2145-2157 , 2018
Link: https://doi.org/10.1002/..
 
?
12

Safety, tolerability, and pharmacokinetics of AL-335 in hea..:

McClure, Matthew W. ; Berliba, Elina ; Tsertsvadze, Tengiz...
PLOS ONE.  13 (2018)  10 - p. e0204974 , 2018
Link: https://doi.org/10.1371/..
 
?
13

Single‐ and multiple‐dose pharmacokinetics and safety of pi..:

Deleu, Sofie ; Kakuda, Thomas N. ; Spittaels, Kurt...
British Journal of Clinical Pharmacology.  84 (2018)  11 - p. 2663-2672 , 2018
Link: https://doi.org/10.1111/..
 
?
14

Characterizing the Pharmacokinetic Interaction Between Sime..:

Valade, Elodie ; Valenzuela, Belén ; Kakuda, Thomas N....
The AAPS Journal.  20 (2018)  6 - p. , 2018
Link: https://doi.org/10.1208/..
 
?
15

Efficacy, safety and pharmacokinetics of simeprevir and TMC..:

Bourgeois, Stefan ; Van Vlierberghe, Hans ; Moreno, Christophe...
BMC Gastroenterology.  17 (2017)  1 - p. , 2017
Link: https://doi.org/10.1186/..
 
1-15